Calculation of Lipophilicity: A Classification of Methods

Pharmacokinetic Profiling in Drug Research

Volumn , Issue , 2007, Pages 331-352

  Mannhold, Raimund ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Calculation of lipophilicity; Classification of methods; Computational strategies; Drug bioactivity; Drug disposition

Indexed keywords

COMPUTATIONAL STRATEGY; DRUG DISPOSITION; LIPOPHILICITY;

EID: 84956610645     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783906390468.ch19     Document Type: Chapter

References (64)

1. V. Pliska, B. Testa, H. van de Waterbeemd, 'Lipophilicity in Drug Action and Toxicology ä, VCH,Weinheim, 1996.
2. P.-A. Carrupt, B. Testa, P. Gaillard, in 'Reviews in Computational Chemistryä, Eds. K. B. Lipkowitz, D. B. Boyd, Wiley-VCH, Weinheim, 1997, Vol. 11, p. 241-315.
3. C. A. Lipinski, F. Lombardo,B.W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3.
4. H. van de Waterbeemd, E. Gifford, Nat. Drug Discov. Rev. 2003, 2, 192.
5. F. Lombardo, E. Gifford, M. Y. Shalaeva, Mini-Rev. Med. Chem. 2003, 3, 861.
6. T. Fujita, J. Iwasa, J. C. Hansch, J. Am. Chem. Soc. 1964, 86, 5175.
7. G. G. Nys, R. F. Rekker, Chim. Ther. 1973, 8, 521.
8. G. G. Nys, R. F. Rekker, Chim. Ther. 1974, 9, 361.
9. R. F. Rekker, 'The Hydrophobic Fragmental Constant. Its Derivation and Application ä, Elsevier, Amsterdam, 1977.
10. R. F. Rekker, H. M. de Kort, Eur. J. Med. Chem. 1979, 14, 479.
11. P. Broto, G. Moreau, C. Vandycke, Eur. J. Med. Chem. 1984, 19, 71.
12. T. Masuda, T. Jikihara, K. Nakamura, A. Kimura, T. Takagi, H. Fujiwara, J. Pharm. Sci. 1997, 86, 57.
13. N. G. J. Richards, P. B. Williams, M. S. Tute, Int. J. Quantum Chem., Quantum Biol. Symp. 1991, 40(S18), 299.
14. N. G. J. Richards, P. B.Williams, M. S. Tute, Int. J. Quantum Chem. 1992, 44, 219.
15. E. Audry, J.-P. Dubost, J.-C. Colleter, P. Dallet, Eur. J. Med. Chem. 1986, 21, 71.
16. J.-L. Fauch're, P. Quarendon, L. Kaetterer, J. Mol. Graphics 1988, 6, 203.
17. P. Furet, A. Sele, N. C. Cohen, J. Mol. Graphics 1988, 6, 182.
18. A. J. Leo, P. Y. C. Jow, C. Silipo, C. Hansch, J. Med. Chem. 1975, 18, 865.
19. C. Hansch, A. J. Leo, 'Substituent Constants for Correlation Analysis in Chemistry and Biologyä,Wiley, New York, 1979.
20. A. J. Leo, J. Pharm. Sci. 1987, 76, 166.
21. A. J. Leo, Methods Enzymol. 1991, 202, 544.
22. A. J. Leo, Chem. Rev. 1993, 93, 1281.
23. J. T. Chou, P. C. Jurs, J. Chem. Inf. Comput. Sci. 1979, 19, 172.
24. A. J. Leo, D. Hoekman, Perspect. Drug Discov. Des. 2000, 18, 19.
25. R. F. Rekker,R.Mannhold, 'Calculation ofDrug Lipophilicityä,VCH,Weinheim, 1992.
26. R. Mannhold, R. F. Rekker, K. Dross,G. Bijloo,G. de Vries, Quant. Struct.-Act. Relat. 1998, 17, 517.
27. D. E. Petelin, N. A. Arslanov, V. A. Palyulin, N. S. Zefirov, in 'Proceedings of the 10th European Symposium on Structure-Activity Relationshipsä, Prous Science Publishers, Barcelona, 1995, abstract B263.
28. G. Klopman, J.W. Li, S.Wang, M. Dimayuga, J. Chem. Inf. Comput. Sci. 1994, 34, 752.
29. W. M. Meylan, P. H. Howard, J. Pharm. Sci. 1995, 84, 83.
30. A. A. Petrauskas, E. A. Kolovanov, Perspect. Drug Discov. Des. 2000, 19, 99.
31. A. A. Petrauskas, E. A. Kolovanov, 13th European Symposium on Quantitative Structure-Activity Relationships, Abstract Book P.4, D'sseldorf, 2000.
32. P. Japertas, R. Didziapetris, A. A. Petrauskas, Quant. Struct.-Act. Relat. 2002, 21, 23.
33. A. K. Ghose, G. M. Crippen, J. Comput. Chem. 1986, 7, 565.
34. A. K. Ghose, G. M. Crippen, J. Chem. Inf. Comput. Sci. 1987, 27, 21.
35. A. K. Ghose, A. Pritchett, G. M. Crippen, J. Comput. Chem. 1988, 9, 80.
36. V. N.Viswanadhan, A. K. Ghose,G. R. Revankar, R. K. Robins, J. Chem. Inf. Comput. Sci. 1989, 29, 163.
37. A. K. Ghose, V. N. Viswanadhan, J. J. Wendoloski, J. Phys. Chem. A 1998, 102, 3762.
38. S. A. Wildman, G. M. Crippen, J. Chem. Inf. Comput. Sci. 1999, 39, 868.
39. R. Wang, Y. Fu, L. Lai, J. Chem. Inf. Comput. Sci. 1999, 39, 868.
40. R. Wang, Y. Gao, L. Lai, Perspect. Drug Discov. Des. 2000, 19, 47.
41. P. Gaillard, P.-A. Carrupt,B. Testa, A. Boudon, J. Comput.-Aided Mol. Des. 1994, 8, 83.
42. G. E. Kellogg, S. F. Semus, D. J. Abraham, J. Comput.-Aided Mol. Des. 1991, 5, 545.
43. G. E. Kellogg, G. J. Joshi, D. J. Abraham, Med. Chem. Res. 1992, 1, 444.
44. D. J. Abraham, G. E. Kellogg, J. Comput.-Aided Mol. Des. 1994, 8, 41.
45. G. E. Kellogg, D. J. Abraham, Analusis 1999, 2, 19.
46. G. E. Kellogg, D. J. Abraham, Eur. J. Med. Chem. 2000, 35, 651.
47. I. Moriguchi, S. Hirono,Q. Liu, I. Nakagome,Y. Matsushita, Chem. Pharm. Bull. 1992, 40, 127.
48. V. K. Gombar, K. Enslein, J. Chem. Inf. Comput. Sci. 1996, 36, 1127.
49. V. K. Gombar, SAR QSAR Environ. Res. 1999, 10, 371.
50. M. Junghans, E. Pretsch, Fresenius J. Anal. Chem. 1997, 359, 88.
51. N. Bodor, M. J. Huang, J. Pharm. Sci. 1992, 81, 272.
52. J. Devillers, D. Domine, C. Guillon, W. Karcher, J. Pharm. Sci. 1998, 87, 1086.
53. G. Klopman, L. D. Iroff, J. Comput. Chem. 1981, 2, 157.
54. N. Bodor, Z. Gabanyi, C. K. Wong, J. Am. Chem. Soc. 1989, 111, 3783.
55. N. Bodor, P. Buchwald, J. Phys. Chem. B 1997, 101, 3404.
56. A.Avdeef, in 'Lipophilicity in Drug Action andToxicologyä, Eds.V. Pliska,B. Testa, H. van de Waterbeemd, VCH,Weinheim, 1996, p. 109-139.
57. J. Comer, in 'Drug Bioavailabilityä, Eds. H. van de Waterbeemd, H. Lennern s, P. Artursson,Wiley-VCH,Weinheim, 2003, p. 21 -45.
58. O. A. Raevsky, SAR QSAR Environ. Res. 2001, 12, 367.
59. O. A. Raevsky, S. V. Trepalin, H. P. Trepalina, V. A. Gerasimenko, O. E. Raevskaja, J. Chem. Inf. Comput. Sci. 2002, 42, 540.
60. H. van de Waterbeemd, R. Mannhold, in 'Lipophilicity in Drug Action and Toxicology ä, Eds. V. Pliska, B. Testa, H. van de Waterbeemd, VCH, Weinheim, 1996, p. 401 -418.
61. R. Mannhold, H. van de Waterbeemd, J. Comput.-Aided Mol. Des. 2001, 15, 337.
62. P. Buchwald, N. Bodor, Curr. Med. Chem. 1998, 5, 353.
63. I. V. Tetko, Mini-Rev. Med. Chem. 2003, 3, 809.
64. I. V. Tetko, V. Y. Tanchuk, LogP2004 Symposium, ETH Z'rich, Abstract Book C-11, 2004.